Citation Impact
Citing Papers
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
2011
Physical Interaction of Calmodulin with the 5-Hydroxytryptamine 2C Receptor C-Terminus Is Essential for G Protein-independent, Arrestin-dependent Receptor Signaling
2008
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors
1997
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease
2008
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice
2009
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists
1997
The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats
2002
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Strain and Gender Specific Effects in the Forced Swim Test: Effects of Previous Stress Exposure
2003
Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors
2005
Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia
2003
Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone
2003
Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice
2006
Descending control of pain
2002 Standout
Glutamate uptake
2001 Standout
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
2010 Standout
Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone
2003
The effects of chronic mild stress on male Sprague–Dawley and Long Evans rats
2002
Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT 2C receptors in Wistar rats
2003
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains
2001
ChEMBL: a large-scale bioactivity database for drug discovery
2011 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Pharmacological targeting of the serotonergic system for the treatment of obesity
2008
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Psychedelics
2016 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Melatonin and its analogs in insomnia and depression
2011
Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine
2009
Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells
2008
Catalytic Asymmetric Reductive Amination of α‐Branched Ketones
2010 StandoutNobel
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
2017
Constitutive Activity of the Serotonin2C Receptor InhibitsIn VivoDopamine Release in the Rat Striatum and Nucleus Accumbens
2004
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
1997
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
2012 Standout
Pharmacology of nociceptin and its receptor: a novel therapeutic target
2000
Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants
2008
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
2003
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Stimulation of 5‐hydroxytryptamine (5‐HT2C) receptors in the ventrotegmental area inhibits stress‐induced but not basal dopamine release in the rat prefrontal cortex
2002
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
2011
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
2000
The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference
2005
Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus
2006
DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation
2012
Pharmacological agents acting at subtypes of metabotropic glutamate receptors
1999
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
5‐HT 2C receptor modulation and the treatment of obesity
1999
Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors
2006
A review of central 5-HT receptors and their function
1999 Standout
Major Depressive Disorder
2008 Standout
The neural basis of psychedelic action
2022 Standout
Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats
2007
Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target
2013 Standout
Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice
2005
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Serotonin and decision making processes
2011
Characterisation of an uridine-specific binding site in rat cerebrocortical homogenates
2003
Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences
2000
The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways
2003
Aversive stimulus properties of the 5-HT2C receptor agonist WAY 161503 in rats
2006
Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine
2002
Discovery of N-(2-hydroxy-2-aryl-cyclohexyl) substituted spiropiperidines as GlyT1 antagonists with improved pharmacological profile
2005
Brain serotonin system in the coordination of food intake and body weight
2010
Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference
2002
Endogenous serotonin and serotonin2Creceptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade
2008
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO60-0175: a pharmacological analysis
1999
Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats
2008
Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists
2001
European Guidelines for Obesity Management in Adults
2015 Standout
Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability
2006
8-OH-DPAT-induced Spontaneous Tail-flicks in the Rat are Facilitated by the Selective Serotonin (5-HT) 2C Agonist, RO 60-0175: Blockade of its Actions by the Novel 5-HT 2C Receptor Antagonist SB 206,553
1997
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
ADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
2005 Standout
Pharmacological Approaches for the Treatment of Obesity
2002
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy
2001
Catalytic Asymmetric Reductive Amination of α‐Branched Ketones
2010 StandoutNobel
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000
The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?
2000
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Works of J. Wichmann being referenced
Characterization of (2S,2′R,3′R)‐2‐(2′,3′‐[3H]‐Dicarboxycyclopropyl)glycine Binding in Rat Brain
1998
8-Acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists
1999
Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties
2000
5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats
1996
S-17-5 5HT2C receptor agonists and antagonists in animal models of anxiety
1995
5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential
1998